메뉴 건너뛰기




Volumn 33, Issue 10-11, 2009, Pages 984-986

Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): A randomized controlled pilot trial

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PENTOXIFYLLINE;

EID: 70350375687     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.05.010     Document Type: Letter
Times cited : (11)

References (16)
  • 1
    • 67349114309 scopus 로고    scopus 로고
    • Stéatopathie métabolique : définition et histoire naturelle
    • Lemoine M. Stéatopathie métabolique : définition et histoire naturelle. Gastroenterol Clin Biol 33 (2009) 398-404
    • (2009) Gastroenterol Clin Biol , vol.33 , pp. 398-404
    • Lemoine, M.1
  • 3
    • 34548494820 scopus 로고    scopus 로고
    • Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with non-alcoholic steatohepatitis
    • Duman D.G., Ozdemir F., Birben E., Keskin O., Eksioglu-demiralp E., Celikel C., et al. Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with non-alcoholic steatohepatitis. Dig Dis Sci 52 (2007) 2520-2524
    • (2007) Dig Dis Sci , vol.52 , pp. 2520-2524
    • Duman, D.G.1    Ozdemir, F.2    Birben, E.3    Keskin, O.4    Eksioglu-demiralp, E.5    Celikel, C.6
  • 4
    • 4644224457 scopus 로고    scopus 로고
    • Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet
    • Koppe S.W., Sahai A., Malladi P., Whitington P.F., and Green R.M. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol 41 (2004) 592-598
    • (2004) J Hepatol , vol.41 , pp. 592-598
    • Koppe, S.W.1    Sahai, A.2    Malladi, P.3    Whitington, P.F.4    Green, R.M.5
  • 5
    • 34547843608 scopus 로고    scopus 로고
    • Amelioration of steatohepatitis with pentoxifylline in a novel non-alcoholic steatohepatitis model induced by high-fat diet
    • Yalniz M., Bahceioglu I.H., Kuzu N., Celebi S., Ataseven H., Ustündag B., et al. Amelioration of steatohepatitis with pentoxifylline in a novel non-alcoholic steatohepatitis model induced by high-fat diet. Dig Dis Sci 52 (2007) 2380-2386
    • (2007) Dig Dis Sci , vol.52 , pp. 2380-2386
    • Yalniz, M.1    Bahceioglu, I.H.2    Kuzu, N.3    Celebi, S.4    Ataseven, H.5    Ustündag, B.6
  • 6
    • 33645789349 scopus 로고    scopus 로고
    • Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis
    • Vial P., Riquelme A., Pizarro M., Solis N., Madariaga J.A., Aguayo G., et al. Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. Ann Hepatol 5 (2006) 25-29
    • (2006) Ann Hepatol , vol.5 , pp. 25-29
    • Vial, P.1    Riquelme, A.2    Pizarro, M.3    Solis, N.4    Madariaga, J.A.5    Aguayo, G.6
  • 7
    • 34047271926 scopus 로고    scopus 로고
    • Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study
    • Georgescu E.F., and Georgescu M. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. J Gastrointestin Liver Dis 16 (2007) 39-46
    • (2007) J Gastrointestin Liver Dis , vol.16 , pp. 39-46
    • Georgescu, E.F.1    Georgescu, M.2
  • 8
    • 34247210640 scopus 로고    scopus 로고
    • Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis
    • Satapathy S.K., Sakhuja P., Malhotra V., Sharma B.C., and Sarin S.K. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 22 (2007) 634-644
    • (2007) J Gastroenterol Hepatol , vol.22 , pp. 634-644
    • Satapathy, S.K.1    Sakhuja, P.2    Malhotra, V.3    Sharma, B.C.4    Sarin, S.K.5
  • 9
    • 20044374023 scopus 로고    scopus 로고
    • Design and validation of a histological scoring system for nonalcoholic fatty liver disease
    • Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
    • (2005) Hepatology , vol.41 , pp. 1313-1321
    • Kleiner, D.E.1    Brunt, E.M.2    Van Natta, M.3    Behling, C.4    Contos, M.J.5    Cummings, O.W.6
  • 10
    • 19144365586 scopus 로고    scopus 로고
    • A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
    • Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100 (2005) 1082-1090
    • (2005) Am J Gastroenterol , vol.100 , pp. 1082-1090
    • Bugianesi, E.1    Gentilcore, E.2    Manini, R.3    Natale, S.4    Vanni, E.5    Villanova, N.6
  • 11
    • 37549047166 scopus 로고    scopus 로고
    • Metformin is effective in achieving biochemical response in patients with non-alcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions
    • Duseja A., Das A., Dhiman R.K., Chawla Y.K., Thumburu K.T., Bhadada S., et al. Metformin is effective in achieving biochemical response in patients with non-alcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol 6 (2007) 222-226
    • (2007) Ann Hepatol , vol.6 , pp. 222-226
    • Duseja, A.1    Das, A.2    Dhiman, R.K.3    Chawla, Y.K.4    Thumburu, K.T.5    Bhadada, S.6
  • 12
    • 57649229536 scopus 로고    scopus 로고
    • Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis
    • Loomba R., Lutchman G., Kleiner D.E., Ricks M., Feld J.J., Borg B.B., et al. Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Aliment Pharmacol Ther 29 (2008) 172-182
    • (2008) Aliment Pharmacol Ther , vol.29 , pp. 172-182
    • Loomba, R.1    Lutchman, G.2    Kleiner, D.E.3    Ricks, M.4    Feld, J.J.5    Borg, B.B.6
  • 13
    • 16444378976 scopus 로고    scopus 로고
    • A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis
    • Schwimmer J.B., Middleton M.S., Deutsch R., and Lavine J.E. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21 (2005) 871-879
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 871-879
    • Schwimmer, J.B.1    Middleton, M.S.2    Deutsch, R.3    Lavine, J.E.4
  • 15
    • 11144249271 scopus 로고    scopus 로고
    • A pilot trial of pentoxifylline in non-alcoholic steatohepatitis
    • Adams La, Zein Co, Angulo P., and Lindor K.D. A pilot trial of pentoxifylline in non-alcoholic steatohepatitis. Am J Gastroenterol 99 (2004) 2365-2368
    • (2004) Am J Gastroenterol , vol.99 , pp. 2365-2368
    • Adams La1    Zein Co2    Angulo, P.3    Lindor, K.D.4
  • 16
    • 7044269614 scopus 로고    scopus 로고
    • Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with non-alcoholic steatohepatitis
    • Satapathy S.K., Garg S., Chauhan R., Sakhuja P., Malhotra V., Sharma B.C., et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with non-alcoholic steatohepatitis. Am J Gastroenterol 99 (2004) 1946-1952
    • (2004) Am J Gastroenterol , vol.99 , pp. 1946-1952
    • Satapathy, S.K.1    Garg, S.2    Chauhan, R.3    Sakhuja, P.4    Malhotra, V.5    Sharma, B.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.